CERCI, K.; PATIR, P. Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation. Global Journal of Medical and Clinical Case Reports, [S. l.], v. 10, n. 1, p. 001–002, 2023. DOI: 10.17352/2455-5282.000167. Disponível em: https://www.organscigroup.com/gjmccr/article/view/GJMCCR-10-267. Acesso em: 1 jan. 2025.